T1	Participants 38 59	chronic heart failure
T2	Participants 141 191	patients with advanced chronic heart failure (CHF)
T3	Participants 324 341	patients with CHF
T4	Participants 374 455	23 patients in NYHA class II and III (20 men, three women, mean age 59+/-9 years)
T5	Participants 663 731	CoQ(10) (100 mg tid), CoQ(10) plus supervised exercise training (ET)
